Study of the beneficial effect of Canagliflozin on nocturnal home BP in Japanese T2DM patients(SHIFT-J STUDY)
Phase of Trial: Phase II
Latest Information Update: 14 Dec 2017
At a glance
- Drugs Canagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms SHIFT-J
- 12 Dec 2017 Status changed from recruiting to completed.
- 02 Sep 2016 Status changed from not yet recruiting to recruiting.
- 05 Aug 2016 New trial record